None
Quote | Veracyte Inc. (NASDAQ:VCYT)
Last: | $21.26 |
---|---|
Change Percent: | -0.19% |
Open: | $21.37 |
Close: | $21.26 |
High: | $21.73 |
Low: | $21.1 |
Volume: | 574,463 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
News | Veracyte Inc. (NASDAQ:VCYT)
Findings presented at the ENDO 2024 conference Veracyte, Inc . (Nasdaq: VCYT), a leading cancer diagnostics company, today announced new research findings suggesting the potential of novel molecular signatures to identify patients with thyroid nodules or cancer who have aggressive d...
Veracyte, Inc . (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that data from three studies will demonstrate the power of the Afirma GRID (Genomic Resource for Intelligent Discovery) tool to help unlock new molecular insights into thyroid tumors, which may ultimately help...
Message Board Posts | Veracyte Inc. (NASDAQ:VCYT)
Subject | By | Source | When |
---|---|---|---|
Anyone hear anything lately? Want to see this one go | Alan Brown | investorshub | 04/25/2023 10:31:30 PM |
must see | gumibear | investorshub | 04/24/2023 8:49:57 PM |
short squeeze signal | Gixene | investorshub | 04/23/2023 7:42:51 AM |
what does this mean? | ClayTrader | investorshub | 04/23/2023 7:13:01 AM |
$VCYT The gaining | Alan Brown | investorshub | 04/23/2023 6:40:05 AM |
News, Short Squeeze, Breakout and More Instantly...
Findings presented at the ENDO 2024 conference Veracyte, Inc . (Nasdaq: VCYT), a leading cancer diagnostics company, today announced new research findings suggesting the potential of novel molecular signatures to identify patients with thyroid nodules or cancer who have aggressive d...
Veracyte, Inc . (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that data from three studies will demonstrate the power of the Afirma GRID (Genomic Resource for Intelligent Discovery) tool to help unlock new molecular insights into thyroid tumors, which may ultimately help...
Grew total revenue to $96.8 million, an increase of 17% Grew testing revenue by 25% Conference call and webcast today at 4:30 p.m. ET Veracyte, Inc. (Nasdaq: VCYT) today announced financial results for the first quarter ended March 31, 2024. “We had a strong s...